**Core Concept**
Bone metastasis refers to the spread of cancer cells from a primary site to the bone microenvironment, leading to disruption of normal bone physiology and potential skeletal complications. This process involves complex interactions between cancer cells, bone cells (osteoblasts and osteoclasts), and the bone matrix.

**Why the Correct Answer is Right**
Bone metastasis often leads to increased osteoclastic activity, resulting in bone destruction and lytic lesions. The RANK-RANKL-OPG pathway plays a crucial role in regulating osteoclast activity, with RANKL promoting osteoclast formation and activation. In the context of bone metastasis, cancer cells can produce factors that stimulate RANKL expression, leading to increased osteoclast activity and bone destruction.

**Why Each Wrong Option is Incorrect**
**Option A:** Bone metastasis can indeed cause an increase in osteoblastic activity, leading to sclerotic (dense) bone lesions, particularly in cancers such as prostate and breast cancer.
**Option B:** Bone metastasis can disrupt the normal balance between bone resorption and formation, leading to a net increase in bone resorption and potential skeletal complications.
**Option C:** Bone metastasis can indeed cause an increase in bone markers such as alkaline phosphatase and osteocalcin, reflecting the abnormal bone remodeling process.

**Clinical Pearl / High-Yield Fact**
The most common cancers that metastasize to bone are breast, prostate, lung, and kidney cancer, and understanding the underlying mechanisms of bone metastasis is crucial for managing skeletal-related complications in these patients.

**Correct Answer:** D.